A perspective on intermittent fasting and cardiovascular risk in the era of obesity pharmacotherapy
Intermittent fasting has been linked to metabolic health by improving lipid profiles, reducing body weight, and increasing insulin sensitivity. However, several randomized clinical trials have shown that intermittent fasting is not more effective than standard daily caloric restriction for short-ter...
Saved in:
Main Authors: | Aristides G. Eliopoulos, Kalliopi K. Gkouskou, Konstantinos Tsioufis, Despina Sanoudou |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Nutrition |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fnut.2025.1524125/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparison of GLP-1RAs vs Other Pharmacotherapy for Obesity
by: Andrew Overholser, et al.
Published: (2025-02-01) -
The Impact of Intermittent Fasting: Enhancing Health and Mitigating Disease Risks
by: Alicja Grzelak
Published: (2025-01-01) -
Intermittent Fasting: Weighing the Benefits and Drawbacks for Health and Longevity – A Comprehensive Literature Review
by: Marta Wojtczak, et al.
Published: (2025-01-01) -
Intermittent fasting: Effectiveness and safety. A review
by: Marina V. Altashina, et al.
Published: (2024-12-01) -
Comprehensive Analysis of Intermittent Fasting on Anthropometric Indices, Glycemic Control, and Serum Insulin Levels in Obese Patients with Type 2 Diabetes
by: Aparnna Unnikrishnan Nair, et al.
Published: (2024-12-01)